연구동향 분석
박사

알코올 간질환 환자에서 비타민 B6, 비타민 B12 그리고 엽산 투여 효과

고순영 2015년

논문상세정보
인용/피인용
' 알코올 간질환 환자에서 비타민 B6, 비타민 B12 그리고 엽산 투여 효과' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • alcoholic liver disease
  • folate
  • methionine
  • 메치오닌
  • 알코올 간질환
  • 엽산
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
47 0

0.0%

' 알코올 간질환 환자에서 비타민 B6, 비타민 B12 그리고 엽산 투여 효과' 의 참고문헌

  • Villanueva, J. A., F. Esfandiari, M. E. White, S. Devaraj, S. W. French and C.H. Halsted (2007), "S-adenosylmethionine attenuates oxidative liver injuryin micropigs fed ethanol with a folate-deficient diet," Alcohol Clin Exp Res,31(11): 1934-1943.
  • Tsukamoto, H. and S. C. Lu (2001), "Current concepts in the pathogenesisof alcoholic liver injury," FASEB J, 15(8): 1335-1349.
  • Torruellas, C., S. W. French and V. Medici (2014), "Diagnosis of alcoholicliver disease," World J Gastroenterol, 20(33): 11684-11699.
  • Thurman, R. G., B. U. Bradford, Y. Iimuro, K. T. Knecht, G. E. Arteel, M.Yin, H. D. Connor, C. Wall, J. A. Raleigh, M. V. Frankenberg, Y. Adachi, D.T. Forman, D. Brenner, M. Kadiiska and R. P. Mason (1998), "The role of39gut-derived bacterial toxins and free radicals in alcohol-induced liverinjury," J Gastroenterol Hepatol, 13 Suppl: S39-50.
  • Teli, M. R., C. P. Day, A. D. Burt, M. K. Bennett and O. F. James (1995),"Determinants of progression to cirrhosis or fibrosis in pure alcoholic fattyliver," Lancet, 346(8981): 987-990.
  • Stewart, S. H. (2002), "Racial and ethnic differences in alcohol-associatedaspartate aminotransferase and gamma-glutamyltransferase elevation,"Arch Intern Med, 162(19): 2236-2239.
  • Stabler, S. P. and R. H. Allen (2004), "Quantification of serum and urinaryS-adenosylmethionine and S-adenosylhomocysteine by stable-isotopedilutionliquid chromatography-mass spectrometry," Clin Chem , 50(2):365-372.
  • Shinohara, M., C. Ji and N. Kaplowitz (2010), "Differences in betainehomocysteinemethyltransferase expression, endoplasmic reticulum stressr e s p o n s e , a n d l i v e r i n j u r y b e t w e e n a l c o h o l - f e d m i c e a n d r a t s , "Hepatology, 51(3): 796-805.
  • Setshedi, M., J. R. Wands and S. M. Monte (2010), "Acetaldehyde adductsin alcoholic liver disease," Oxid Med Cell Longev 3(3): 178-185.
  • Raynard, B., A. Balian, D. Fallik, F. Capron, P. Bedossa, J. C. Chaput and S.Naveau (2002), "Risk factors of fibrosis in alcohol-induced liver disease,"Hepatology, 35(3): 635-638.
  • Rao, R. (2009), "Endotoxemia and gut barrier dysfunction in alcoholic liverdisease," Hepatology, 50(2): 638-644.
  • Rambaldi, A. and C. Gluud (2006), "S-adenosyl-L-methionine for alcoholicliver diseases," Cochrane Database Syst Rev,(2):CD002235.
  • Orman, E. S., G. Odena, and R. Bataller (2013), Alcoholic liver disease:pathogenesis, management, and novel targets for therapy," J GastroenterolHepatol, 28 Suppl 1: 77-84.
  • O'Shea, R. S., S. Dasarathy, and A. J. McCullough (2010), "Alcoholic liverdisease," Hepatology, 51(1): 307-328.
  • O'Connor, P. G. and R. S. Schottenfeld (1998), "Patients with alcoholproblems," N Engl J Med, 338(9): 592-602.
  • Naveau, S., V. Giraud, E. Borotto, A. Aubert, F. Capron and J. C. Chaput(1997), "Excess weight risk factor for alcoholic liver disease," Hepatology,25(1): 108-111.
  • Medici, V., M. C. Virata, J. M. Peerson, S. P. Stabler, S. W. French, J. F.Gregory, 3rd, A. Albanese, C. L. Bowlus, S. Devaraj, E. A. Panacek, J. R.Richards and C. H. Halsted (2011), "S-adenosyl-L-methionine treatmentfor alcoholic liver disease: a double-blinded, randomized, placebo-controlledtrial," Alcohol Clin Exp Res, 35(11): 1960-1965.
  • Medici, V., J. M. Peerson, S. P. Stabler, S. W. French, J. F. Gregory, 3rd, M.C. Virata, A. Albanese, C. L. Bowlus, S. Devaraj, E. A. Panacek, N. Rahim, J.R. Richards, L. Rossaro and C. H. Halsted (2010), "Impaired homocysteinetranssulfuration is an indicator of alcoholic liver disease," J Hepatol, 53(3):551-557.
  • Medici, V. and C. H. Halsted (2013), "Folate, alcohol, and liver disease,"Mol Nutr Food Res, 57(4): 596-606.
  • Lumeng, L. and D. W. Crabb (2001), "Alcoholic liver disease," Curr OpinGastroenterol, 17(3): 211-220.
  • Look, M. P., R. Riezler, C. Reichel, K. A. Brensing, J. K. Rockstroh, S. P.Stabler, U. Spengler, H. K. Berthold and T. Sauerbruch (2000), "Is theincrease in serum cystathionine levels in patients with liver cirrhosis aconsequence of impaired homocysteine transsulfuration at the level ofgamma-cystathionase?" Scand J Gastroenterol, 35(8): 866-872.
  • Lieber, C. S., D. P. Jones and L. M. Decarli (1965), "Effects of ProlongedEt ha nol Inta ke: P roduct ion of Fatt y Liver D es pit e Adequat e Diets ,"J Clin Invest, 44:1009-1021.
  • Lieber, C. S., D. G. Weiss, R. Groszmann, F. Paronetto and S. Schenker(2003), "I. Veterans Affairs Cooperative Study of polyenylphosphatidylcholinein alcoholic liver disease: effects on drinking behavior by nurse/physicianteams." Alcohol Clin Exp Res, 27(11): 1757-1764.
  • Lieber, C. S. (1994), "Susceptibility to alcohol-related liver injury,"Alcohol Alcohol Suppl, 2: 315-326.
  • Lee, T. D., M. R. Sadda, M. H. Mendler, T. Bottiglieri, G. Kanel, J. M. Mato35and S . C . L u (2004) , "Abnormal hepat ic methionine and glutathionemetabolism in patients with alcoholic hepatitis," Alcohol Clin Exp Res, 28(1):173-181.
  • Kharbanda, K. K., M. E. Mailliard, C. R. Baldwin, H. C. Beckenhauer, M. F.Sorrell and D. J. Tuma (2007), "Betaine attenuates alcoholic steatosis byrestoring phosphatidylcholine generation via the phosphatidylethanolaminemethyltransferase pathway," J Hepatol, 46(2): 314-321.
  • Kharbanda, K. K. (2013), "Methionine metabolic pathway in alcoholic liverinjury," Curr Opin Clin Nutr Metab Care, 16(1): 89-95.
  • Kh a rba n da , K . K. ( 2009) , "A lc oh ol ic li ve r d is ea s e a n d met hi on in emetabolism," Semin Liver Dis, 29(2): 155-165.
  • Kanazawa, S. and V. Herbert (1985), "Total corrinoid, cobalamin (vitaminB12), and cobalamin analogue levels may be normal in serum despitecobalamin in liver depletion in patients with alcoholism," Lab Invest , 53(1):108-110.
  • Ji, C. (2012), "Mechanisms of alcohol-induced endoplasmic reticulum stressand organ injuries," Biochem Res Int, 2012: 216450.
  • Hoek, J. B., A. Cahill and G. Pastorino (2002), "Alcohol and mitochondria: a34dysfunctional relationship," Gastroenterology, 122(7): 2049-2063.
  • Hatton, J., A. Burton, H. Nash, E. Munn, L. Burgoyne and N. Sheron (2009),"Drinking patterns, dependency and life-time drinking history in alcoholrelatedliver disease," Addiction, 104(4): 587-592.
  • Halsted, C. H., J. A. Villanueva, A. M. Devlin, O. Niemela, S. Parkkila, T. A.Garrow, L. M. Wallock, M. K. Shigenaga, S. Melnyk and S. J. James (2002),"Folate deficiency disturbs hepatic methionine metabolism and promotes liverinjury in the ethanol-fed micropig," Proc Natl Acad Sci USA, 99(15):10072-10077.
  • Halsted, C. H. and V. Medici (2011), "Vitamin-dependent methioninemetabolism and alcoholic liver disease," Adv Nutr, 2(5): 421-427.
  • Halsted, C. H. (2004), "Nutrition and alcoholic liver disease," Semin LiverDis, 24(3): 289-304.
  • Ha lst ed, C. H. and V . Medic i ( 2012), "Ab erra nt h epat ic met hioninemetabolism and gene methylation in the pathogenesis and treatment ofalcoholic steatohepatitis," Int J Hepatol, 2012: 959746.
  • Gao, B. and R. Bataller (2011), "Alcoholic liver disease: pathogenesis andnew therapeutic targets," Gastroenterology, 141(5): 1572-1585.
  • Farfan Labonne, B. E., M. Gutierrez, L. E. Gomez-Quiroz, M. KonigsbergFainst ein, L . Bucio, V. Souza, O. F lores, V. O rtiz, E. Hernandez, D.Kershenobich and M. C. Gutierrez-Ruiz (2009), "Acetaldehyde-inducedmitochondrial dysfunction sensitizes hepatocytes to oxidative damage,"Cell Biol Toxicol, 25(6): 599-609.
  • Esfandiari, F., V. Medici, D. H. Wong, S. Jose, M. Dolatshahi, E. Quinlivan, S.Dayal, S. R. Lentz, H. Tsukamoto, Y. H. Zhang, S. W. French and C. H.Halsted (2010), "Epigenetic regulation of hepatic endoplasmic reticulumstress pathways in the ethanol-fed cystathionine beta synthase-deficientmouse," Hepatology, 51(3): 932-941.
  • Esfandiari, F., M. You, .J. A. Villanueva, D. H. Wong, S. W. French and C. H.Halsted (2007), "S-adenosylmethionine attenuates hepatic lipid synthesis inmicropigs fed ethanol with a folate-deficient diet," Alcohol Clin Exp Res ,31(7): 1231-1239.
  • EASL (2012), "EASL clinical practical guidelines: management of alcoholicliver disease," J Hepatol, 57(2): 399-420.
  • Cravo, M. L., L. M. Gloria, J. Selhub, M. R, Nadeau, M. E, Camilo, M. P.Resende,J.N.Cardoso,C.N,LeitaoandF.C.Mira(1996),"Hyperhomocysteinemia in chronic alcoholism: correlation with folate, vitaminB-12, and vitamin B-6 status," Am J Clin Nutr, 63(2): 220-224.
  • Clouston, A. D., J. R. Jonsson and E. Powell (2007), "Steatosis as acofactor in other liver diseases: hepatitis C virus, alcohol, hemochromatosis,and others," Clin Liver Dis, 11(1): 173-189, x.
  • Chen, Y. L., S. S. Yang, H. C. Peng, Y. C. Hsieh, J. R. Chen and S. C. Yang(2011), "Folate and vitamin B12 improved alcohol-induced hyperhomocysteinemiain rats," Nutrition, 27(10): 1034-1039.
  • Bertola, A., O. Park and B. Gao (2013), "Chronic plus binge ethanol feedingsynergistically induces neutrophil infiltration and liver injury in mice: acritical role for E-selectin," Hepatology, 58(5): 1814-1823.
  • Bataller, R., K. E. North and D. A. Brenner (2003), "Genetic polymorphismsand the progression of liver fibrosis: a critical appraisal," Hepatology, 37(3):31493-503.
  • Barak, A. J., H. C. Beckenhauer, D. J. Tuma and S. Badakhsh (1987),"Effects of prolonged ethanol feeding on methionine metabolism in rat liver,"Biochem Cell Biol, 65(3): 230-233.
  • Arteel, G., L. Marsano, C. Mendez, F. Bentley and C. J. McClain (2003),"Advances in alcoholic liver disease," Best Pract Res Clin Gastroenterol ,17(4): 625-647.
  • Anstee, Q. M., A. K. Daly and C. P. Day (2011), "Genetics of alcoholic andnonalcoholic fatty liver disease," Semin Liver Dis, 31(2): 128-146.
  • Altamirano, J. and R. Bataller (2011), "Alcoholic liver disease: pathogenesisand new targets for therapy," Nat Rev Gastroenterol Hepatol, 8(9): 491 -501.
  • Albano, E. and M. Vidali (2010), "Immune mechanisms in alcoholic liverdisease," Genes Nutr, 5(2): 141-147.
  • 33Halsted, C. H. (2013), "B-Vitamin dependent methionine metabolism andalcoholic liver disease," Clin Chem Lab Med, 51(3): 457-465.